Sean Mackay sold $26k of LAB
SVP & Chief Business Officer at STANDARD BIOTOOLS INC.. 25,374 shares at an average of $1.02, traded May 21, 2025, filed May 23, 2025.
Score components
- +15RoleOfficer
- +5Trade size$26k at market
- 0Share of holdings soldSold 2.9% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +14.1%, 3m +38.0%, 6m +50.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-077191, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 21, 2025 | SOpen-market sale Common Stock | -12,838 | $1.03 | $13k | 868,829 | May 23, 2025 |
| May 22, 2025 | SOpen-market sale Common Stock | -12,536 | $1.00 | $13k | 856,293 | May 23, 2025 |
Related signals
Other insiders at STANDARD BIOTOOLS INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $503k 350,000 shares | +0% | |
| 56Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $10M 7,700,000 shares | +12% | |
| 53Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $1.4M 1,075,000 shares | +2% | |
| 53Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $1.1M 925,000 shares | +1% | |
| 53Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $1.4M 1,175,000 shares | +2% | |
| 34Weak | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $129k 100,000 shares | +0% | |
| 43Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $636k 500,000 shares | +1% | |
| 43Moderate | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $659k 525,000 shares | +1% | |
| 35Weak | LABbuy STANDARD BIOTOOLS INC. | Casdin Partners Master Fund, L.P. director, owner | $443k 358,220 shares | +1% | |
| 40Moderate | STANDARD BIOTOOLS INC. | Michael Egholm President & CEO | $5,150 5,473 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.